SCHEMBL9684838

SCHEMBL9684838

CCCCCCCN(CCCCN=C=O)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.52
PAX8 Q06710 1/20 0.52
CNR2 P34972 1/20 0.43
CETP P11597 3/20 0.42
KEAP1 Q14145 2/20 0.42
NFE2L2 Q16236 2/20 0.42
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CCKBR P32239 1/20 0.39
PKM P14618 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27990536 0.86 CCR6 (0.66) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL17275425 0.85 CCR6 (0.61) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL25628629 0.85 CCR6 (0.64) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL9685806 0.84 MAOA (0.46) CCR6PAX8KEAP1NFE2L2ALDH1A1
SCHEMBL9684974 0.84 MAOA (0.46) CCR6PAX8KEAP1NFE2L2ALDH1A1
SCHEMBL15508590 0.84 CCR6 (0.63) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL10822625 0.83 CCR6 (0.62) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL10823180 0.83 CCR6 (0.62) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL10822929 0.83 CCR6 (0.62) CCR6PAX8CNR2CETPALDH1A1
SCHEMBL10822804 0.83 CCR6 (0.62) CCR6PAX8CNR2CETPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513703-A2 Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle MAGIS FARMACEUTICI S.p.A. (IT) 1992-11-19 EP disclosed